4/A

FORM 4/A SUBMISSION

Company: KalVista Pharmaceuticals, Inc.
Filed: May 7, 2021
Period of Report: May 3, 2021
Accession Number: 0001209191-21-031013

View Document ↗ View on SEC.gov ↗